Medicalgorithmics S.A. (MDG.WA)
PLN 25.6
(0.79%)
PLN 25.6
(0.79%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 35.86 Million PLN | -28.79% |
| 2022 | 50.36 Million PLN | -55.5% |
| 2021 | 113.16 Million PLN | 9.67% |
| 2020 | 103.19 Million PLN | -37.67% |
| 2019 | 165.56 Million PLN | -13.01% |
| 2018 | 190.31 Million PLN | -3.44% |
| 2017 | 197.1 Million PLN | 58.2% |
| 2016 | 124.59 Million PLN | 182.22% |
| 2015 | 44.14 Million PLN | 96.53% |
| 2014 | 22.46 Million PLN | 49.76% |
| 2013 | 15 Million PLN | 47.93% |
| 2012 | 10.13 Million PLN | 87.36% |
| 2011 | 5.41 Million PLN | 60.28% |
| 2010 | 3.37 Million PLN | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 5.04 Million PLN | -2193.33% |
| 2024 Q1 | 15 Thousand PLN | -99.84% |
| 2023 Q4 | 9.39 Million PLN | 14.03% |
| 2023 Q2 | 7.69 Million PLN | -26.98% |
| 2023 Q1 | 10.54 Million PLN | -29.66% |
| 2023 Q3 | 8.23 Million PLN | 7.03% |
| 2023 FY | 35.86 Million PLN | -28.79% |
| 2022 Q3 | 10.94 Million PLN | -55.22% |
| 2022 Q1 | 26.89 Million PLN | -8.77% |
| 2022 FY | 50.36 Million PLN | -55.5% |
| 2022 Q4 | 14.98 Million PLN | 36.94% |
| 2022 Q2 | 24.43 Million PLN | -9.15% |
| 2021 Q3 | 29.4 Million PLN | 15.84% |
| 2021 Q2 | 25.38 Million PLN | -12.12% |
| 2021 Q1 | 28.88 Million PLN | 13.84% |
| 2021 FY | 113.16 Million PLN | 9.67% |
| 2021 Q4 | 29.48 Million PLN | 0.26% |
| 2020 FY | 103.19 Million PLN | -37.67% |
| 2020 Q3 | 22.97 Million PLN | 4.84% |
| 2020 Q1 | 32.91 Million PLN | -8.05% |
| 2020 Q4 | 25.37 Million PLN | 10.44% |
| 2020 Q2 | 21.91 Million PLN | -33.41% |
| 2019 Q3 | 40.25 Million PLN | -8.24% |
| 2019 Q4 | 35.79 Million PLN | -11.08% |
| 2019 FY | 165.56 Million PLN | -13.01% |
| 2019 Q1 | 45.64 Million PLN | -15.75% |
| 2019 Q2 | 43.87 Million PLN | -3.88% |
| 2018 Q1 | 42.61 Million PLN | -12.33% |
| 2018 FY | 190.31 Million PLN | -3.44% |
| 2018 Q4 | 54.17 Million PLN | 16.92% |
| 2018 Q3 | 46.33 Million PLN | -1.82% |
| 2018 Q2 | 47.19 Million PLN | 10.73% |
| 2017 Q4 | 48.61 Million PLN | -0.42% |
| 2017 Q1 | 39.64 Million PLN | 13.03% |
| 2017 FY | 197.1 Million PLN | 58.2% |
| 2017 Q2 | 60.03 Million PLN | 51.43% |
| 2017 Q3 | 48.82 Million PLN | -18.67% |
| 2016 Q3 | 39.49 Million PLN | 7.03% |
| 2016 FY | 124.59 Million PLN | 182.22% |
| 2016 Q4 | 35.07 Million PLN | -11.19% |
| 2016 Q1 | 13.31 Million PLN | 6.64% |
| 2016 Q2 | 36.89 Million PLN | 177.08% |
| 2015 FY | 44.14 Million PLN | 96.53% |
| 2015 Q1 | 9.79 Million PLN | 148.21% |
| 2015 Q4 | 12.48 Million PLN | 12.64% |
| 2015 Q3 | 11.08 Million PLN | 2.84% |
| 2015 Q2 | 10.77 Million PLN | 10.03% |
| 2014 Q1 | 5.76 Million PLN | 34.16% |
| 2014 Q2 | 6.17 Million PLN | 7.17% |
| 2014 Q3 | 6.57 Million PLN | 6.47% |
| 2014 Q4 | 3.94 Million PLN | -39.99% |
| 2014 FY | 22.46 Million PLN | 49.76% |
| 2013 Q3 | 3.82 Million PLN | 3.84% |
| 2013 FY | 15 Million PLN | 47.93% |
| 2013 Q2 | 3.68 Million PLN | 15.13% |
| 2013 Q1 | 3.19 Million PLN | 14.25% |
| 2013 Q4 | 4.29 Million PLN | 12.36% |
| 2012 Q4 | 2.79 Million PLN | 4.63% |
| 2012 Q1 | 2.23 Million PLN | 0.0% |
| 2012 FY | 10.13 Million PLN | 87.36% |
| 2012 Q2 | 2.43 Million PLN | 8.72% |
| 2012 Q3 | 2.67 Million PLN | 10.09% |
| 2011 FY | 5.41 Million PLN | 60.28% |
| 2010 FY | 3.37 Million PLN | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Adiuvo Investments S.A. | 983 Thousand PLN | -3548.728% |
| Genomtec S.A. | -793 Thousand PLN | 4622.951% |
| Medinice S.A. | 75 Thousand PLN | -47722.667% |
| Synektik Spólka Akcyjna | 190.86 Million PLN | 81.208% |